T-bet and RORα control lymph node formation by regulating embryonic innate lymphoid cell differentiation

Christina Stehle, Timo Rückert, Rémi Fiancette, Dominika W. Gajdasik, Claire Willis, Carolin Ulbricht, Pawel Durek, Mir-Farzin Mashreghi, Daniela Finke, Anja erika Hauser, David R. Withers, Hyun-Dong Chang, Jakob Zimmermann, Chiara Romagnani*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

The generation of lymphoid tissues during embryogenesis relies on group 3 innate lymphoid cells (ILC3) displaying lymphoid tissue inducer (LTi) activity and expressing the master transcription factor RORγt. Accordingly, RORγt-deficient mice lack ILC3 and lymphoid structures, including lymph nodes (LN). Whereas T-bet affects differentiation and functions of ILC3 postnatally, the role of T-bet in regulating fetal ILC3 and LN formation remains completely unknown. Using multiple mouse models and single-cell analyses of fetal ILCs and ILC progenitors (ILCP), here we identify a key role for T-bet during embryogenesis and show that its deficiency rescues LN formation in RORγt-deficient mice. Mechanistically, T-bet deletion skews the differentiation fate of fetal ILCs and promotes the accumulation of PLZFhi ILCP expressing central LTi molecules in a RORα-dependent fashion. Our data unveil an unexpected role for T-bet and RORα during embryonic ILC function and highlight that RORγt is crucial in counteracting the suppressive effects of T-bet.
Original languageEnglish
Pages (from-to)1231–1244
Number of pages14
JournalNature Immunology
Volume22
Issue number10
Early online date23 Sept 2021
DOIs
Publication statusPublished - Oct 2021

Bibliographical note

Acknowledgements:
We thank J. Kirsch, T. Kaiser (Flow Cytometry Core Facility, Deutsches Rheuma-Forschungszentrum, Berlin) and K. Lehmann (Deutsches Rheuma-Forschungszentrum) for technical help. We thank M. Babic for precise help with detection of LN phenotypes; H.-R. Rodewald (Division for Cellular Immunology, German Cancer Research Center, Heidelberg, Germany) and J. Zhu (Molecular and Cellular Immunoregulation Unit, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA) for providing Il7rcre and Tbx21-ZsGreen mice, respectively; A. Diefenbach and M. Hepworth for scientific discussion; G. Gasteiger, C. Klose, T. Schüler, D. Hernández, J. Zhu and A. Kruglov for critically reading the paper. Funding came from Deutsche Forschungsgemeinschaft (DFG) grants from the Heisenberg Program nos. (RO3565/1-1), RO3565/2-1, SPP 1937 (RO3565/4-1 and 4-2) to C.R., DFG-SFB TRR241 B02 to C.R and B03 to H.D.C., R.M. Schwiete Foundation to H.D.C., Leibniz-Science Campus Chronic Inflammation and Leibniz-Kooperative Exzellenz K259/2019 to C.R. and INST 335/597-1 FUGG. SPP1937 (HA5354/8-1 and 8-2) and TRR130, TP17 to A.E.H, and the state of Berlin and the ‘European Regional Development Fund’ (ERDF 2014–2020, EFRE 1.8/11, Deutsches Rheuma-Forschungszentrum) to M-F.M.)

Fingerprint

Dive into the research topics of 'T-bet and RORα control lymph node formation by regulating embryonic innate lymphoid cell differentiation'. Together they form a unique fingerprint.

Cite this